[
  {
    "criterion": "Reward for accurately documenting the patient-reported response to celecoxib (degree of pain relief, morning stiffness persistence), gastrointestinal tolerance, and the fact that she takes the medication with food",
    "weight": 20,
    "sense": "positive"
  },
  {
    "criterion": "Reward for recording home blood-pressure stability readings and noting relevant family history of hypertension to contextualize NSAID cardiovascular risk",
    "weight": 15,
    "sense": "positive"
  },
  {
    "criterion": "Reward for providing an explicit, evidence-based assessment of osteoarthritis control and a clear plan regarding celecoxib continuation or adjustment, including current dose and frequency",
    "weight": 20,
    "sense": "positive"
  },
  {
    "criterion": "Reward for including forward-looking safety monitoring steps (e.g., periodic blood pressure checks, renal function or GI risk mitigation) consistent with NSAID best-practice guidelines",
    "weight": 15,
    "sense": "positive"
  },
  {
    "criterion": "Penalize for any omission, inaccuracy, or contradiction concerning current celecoxib prescription details (100 mg daily) or confusion with prior meloxicam therapy",
    "weight": 10,
    "sense": "negative"
  },
  {
    "criterion": "Penalize for redundant or irrelevant information copied from the chart or unrelated to the encounter, resulting in unnecessary wordiness",
    "weight": 5,
    "sense": "negative"
  },
  {
    "criterion": "Penalize for failing to document patient safety counseling or clear follow-up instructions (e.g., continue BP monitoring, report GI symptoms, schedule follow-up if pain or BP worsens)",
    "weight": 15,
    "sense": "negative"
  }
]